Kane Biotech: Funding, Investors & Team (Sep 2026)
Kane Biotech Inc., a biotechnology company, engages in the research and development of products to prevent and disperse biofilms in medical and industrial applications. Its products include ALEDEX, an antimicrobial/antibiofilm composition comprising protamine sulfate and chlorhexidine, with applications in anti-infective medical device coatings, animal care and dairy, and food processing industries; DispersinB, an antibiofilm enzyme that inhibits, as well as disperses microbial biofilms, with applications in wound care, medical devices, oral care, and animal healthcare; and a toothpaste and mouthwash additive based on competence stimulating peptide technology for preventing and dispersing dental plaque biofilms. The company was founded in 2001 and is headquartered in Winnipeg, Canada.
Kane Biotech has raised $850k across 1 funding round on record, the most recent an undisclosed round of $850k announced in May 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Kane Biotech Company Profile and Key Stats
Latest funding round on record: May 2026.
Kane Biotech Funding Rounds
Kane Biotech Founders and Leadership Team
Contact details for the Kane Biotech team: 1 has a LinkedIn profile.
Start 14-day free trial →Kane Biotech Funding Compared to Other Biotechnology Startups
Kane Biotech's latest round of $850k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Kane Biotech in Biotechnology and Winnipeg
Companies Similar to Kane Biotech
Medicenna is a clinical-stage immunotherapy company focused on oncology and the development and…
Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective…
Hemostemix Inc. is a Canadian biotechnology company that specializes in creating blood-derived cell therapies…
Avicanna is an organization in the biopharmaceutical sector that concentrates on enhancing medical cannabis…
Edesa Biotech is a privately-held company in the clinical stage that specializes in creating therapies for…
ME Therapeutics is a biotech company that specializes in finding and creating drugs for immuno-oncology that…
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and…
Medicus Pharma is a biotechnology research company that fast-tracks the progress of life sciences and…
ProteinQure is a biotechnology company specializing in creating innovative peptides for various medical…
Anodyne's mission is to create critical chemicals sustainably. Anodyne's approach takes advantage of nature's…
NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and…
ZYUS is a biopharmaceutical company focused on providing patients with cannabinoids and other plant-based…
Kane Biotech Funding FAQs
What does Kane Biotech do?
Kane Biotech Inc., a biotechnology company, engages in the research and development of products to prevent and disperse biofilms in medical and industrial applications. Its products include ALEDEX, an antimicrobial/antibiofilm composition comprising protamine sulfate and chlorhexidine, with applications in anti-infective medical device coatings, animal care and dairy, and food processing industries; DispersinB, an antibiofilm enzyme that inhibits, as well as disperses microbial biofilms, with applications in wound care, medical devices, oral care, and animal healthcare; and a toothpaste and mouthwash additive based on competence stimulating peptide technology for preventing and dispersing dental plaque biofilms. The company was founded in 2001 and is headquartered in Winnipeg, Canada.
How much funding has Kane Biotech raised?
Kane Biotech has raised $850k across 1 round on record. The most recent is an undisclosed round of $850k announced in May 2026.
When did Kane Biotech last raise funding?
Kane Biotech's most recent funding round on record is an undisclosed round of $850k, announced in May 2026.
Who founded Kane Biotech?
FundedIQ lists Marc Edwards (Founder) at Kane Biotech.
Where is Kane Biotech headquartered?
Kane Biotech is based in Winnipeg, Manitoba, Canada.
How many employees does Kane Biotech have?
Kane Biotech is in the 11-50 employee band.
How does Kane Biotech's funding compare to other Biotechnology startups?
Kane Biotech's latest round of $850k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Kane Biotech Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Kane Biotech is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.